TY - JOUR
T1 - Thirty-Day Readmission and Prolonged Length of Stay in Malignant Otitis Externa
AU - Schwam, Zachary G.
AU - Ferrandino, Rocco
AU - Kaul, Vivian Z.
AU - Wanna, George B.
AU - Cosetti, Maura K.
N1 - Publisher Copyright:
© 2019 The American Laryngological, Rhinological and Otological Society, Inc.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Objectives: To determine independent risk factors for 30-day readmission, prolonged length of stay (PLOS), and discharge to a rehabilitation facility for those with malignant otitis externa. Methods: Retrospective cohort study of patients hospitalized with malignant otitis externa (International Classification of Diseases, 9th edition, code 380.14) in the Nationwide Readmissions Database (2013–2014). Overall and disease-specific complication and mortality data were analyzed using chi-squared and multivariate analysis. Results: There were 1267 cases of malignant otitis externa extracted. A PLOS of ≥8 days (90th percentile) was found in 14.2% (n = 180) of patients, and 13.7% (n = 174) were discharged to a facility. Patients were readmitted within 30 days at a rate of 12.5% (n = 159). The overall rates of uncomplicated and complicated diabetes were found to be 42.1% and 17.8%, respectively. Factors independently associated with PLOS included undergoing a surgical procedure (odds ratio [OR] 2.08, P <.001), and having central nervous system complications (OR 3.21, P <.001). Independent risk factors for disposition to a facility included nutritional deficiency (OR 1.91, P =.029), PLOS (OR 4.61, P <.001), and age 65–79 years (OR 6.57, P =.001). Readmission was independently linked to PLOS (OR 3.14, P <.001). Diabetes was not an independent risk factor for any outcome. Conclusions: Thirty-day readmission, PLOS, and ultimate discharge to a rehabilitation facility were common and closely intertwined. Despite the classic association between diabetes and malignant otitis externa, diabetes was not an independent risk factor for any of our outcomes. Level of Evidence: 4 Laryngoscope, 130:2220–2228, 2020.
AB - Objectives: To determine independent risk factors for 30-day readmission, prolonged length of stay (PLOS), and discharge to a rehabilitation facility for those with malignant otitis externa. Methods: Retrospective cohort study of patients hospitalized with malignant otitis externa (International Classification of Diseases, 9th edition, code 380.14) in the Nationwide Readmissions Database (2013–2014). Overall and disease-specific complication and mortality data were analyzed using chi-squared and multivariate analysis. Results: There were 1267 cases of malignant otitis externa extracted. A PLOS of ≥8 days (90th percentile) was found in 14.2% (n = 180) of patients, and 13.7% (n = 174) were discharged to a facility. Patients were readmitted within 30 days at a rate of 12.5% (n = 159). The overall rates of uncomplicated and complicated diabetes were found to be 42.1% and 17.8%, respectively. Factors independently associated with PLOS included undergoing a surgical procedure (odds ratio [OR] 2.08, P <.001), and having central nervous system complications (OR 3.21, P <.001). Independent risk factors for disposition to a facility included nutritional deficiency (OR 1.91, P =.029), PLOS (OR 4.61, P <.001), and age 65–79 years (OR 6.57, P =.001). Readmission was independently linked to PLOS (OR 3.14, P <.001). Diabetes was not an independent risk factor for any outcome. Conclusions: Thirty-day readmission, PLOS, and ultimate discharge to a rehabilitation facility were common and closely intertwined. Despite the classic association between diabetes and malignant otitis externa, diabetes was not an independent risk factor for any of our outcomes. Level of Evidence: 4 Laryngoscope, 130:2220–2228, 2020.
KW - Malignant otitis externa
KW - external otitis
KW - necrotizing otitis externa
KW - otitis externa
KW - skullbase osteomyelitis
UR - http://www.scopus.com/inward/record.url?scp=85075455813&partnerID=8YFLogxK
U2 - 10.1002/lary.28409
DO - 10.1002/lary.28409
M3 - Article
C2 - 31758583
AN - SCOPUS:85075455813
SN - 0023-852X
VL - 130
SP - 2220
EP - 2228
JO - Laryngoscope
JF - Laryngoscope
IS - 9
ER -